Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Veldt, A.A.M. van der
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(55)
+
-
Other
(2)
+
-
Availability
Open access
(49)
+
-
Under embargo
(1)
+
-
Metadata Only
(7)
+
-
Creation Date
2021
(19)
+
-
2022
(13)
+
-
2023
(10)
+
-
2020
(8)
+
-
2024
(3)
+
-
2018
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(44)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(44)
+
-
Scholarly Publications
(13)
+
-
Topic
advanced melanoma
(10)
+
-
immunotherapy
(10)
+
-
melanoma
(8)
+
-
Melanoma
(7)
+
-
targeted therapy
(6)
+
-
Immune checkpoint inhibitors
(4)
+
-
Immunotherapy
(4)
+
-
BRAF mutation
(3)
+
-
Survival
(3)
+
-
immune checkpoint inhibition
(3)
+
-
survival
(3)
+
-
Advanced melanoma
(2)
+
-
COVID-19
(2)
+
-
CTLA-4 inhibitor
(2)
+
-
Metastatic melanoma
(2)
+
-
Nivolumab
(2)
+
-
Older patients
(2)
+
-
Response
(2)
+
-
Targeted therapy
(2)
+
-
checkpoint inhibitors
(2)
+
-
clinical outcomes
(2)
+
-
metastatic melanoma
(2)
+
-
population-based
(2)
+
-
prospective nation-wide data
(2)
+
-
real-world
(2)
+
-
response
(2)
+
-
systemic therapy
(2)
+
-
Show more
Author
Veldt, A.A.M. van der
(57)
+
-
Suijkerbuijk, K.P.M.
(47)
+
-
Aarts, M.J.B.
(46)
+
-
Hospers, G.A.P.
(46)
+
-
Berkmortel, F.W.P.J. van den
(45)
+
-
Groot, J.W.B. de
(44)
+
-
Piersma, D.
(44)
+
-
Eertwegh, A.J.M. van den
(43)
+
-
Rijn, R.S. van
(41)
+
-
Wouters, M.W.J.M.
(41)
+
-
Boers-Sonderen, M.J.
(39)
+
-
Kapiteijn, E.
(39)
+
-
Haanen, J.B.A.G.
(37)
+
-
Vreugdenhil, G.
(37)
+
-
Blank, C.U.
(33)
+
-
Tije, A.J. ten
(18)
+
-
Blokx, W.A.M.
(16)
+
-
Haanen, J.B.
(15)
+
-
Not, O.J. van
(15)
+
-
Akkooi, A.C.J. van
(14)
+
-
Zeijl, M.C.T. van
(12)
+
-
Breeschoten, J. van
(10)
+
-
Hilarius, D.L.
(10)
+
-
Wreede, L.C. de
(10)
+
-
Ismail, R.K.
(8)
+
-
Kapiteijn, E.W.
(8)
+
-
Westgeest, H.M.
(8)
+
-
Franken, M.G.
(7)
+
-
Hoeven, J.J.M. van der
(7)
+
-
Meza, M.M. de
(7)
+
-
Verheijden, R.J.
(6)
+
-
Kooij, M.K. van der
(5)
+
-
Boer, A. de
(4)
+
-
Dartel, M. van
(4)
+
-
Dingemans, A.M.C.
(4)
+
-
Grunhagen, D.J.
(4)
+
-
Herbschleb, K.H.
(4)
+
-
Jalving, M.
(4)
+
-
Joode, K. de
(4)
+
-
Stevense-den Boer, M.A.M.
(4)
+
-
Vreugdenhil, A.
(4)
+
-
Vries, E.G.E. de
(4)
+
-
Acosta, A.T.
(3)
+
-
Bastiaannet, E.
(3)
+
-
Blankenstein, S.A.
(3)
+
-
Boer, M.A.S.D.
(3)
+
-
Bonenkamp, H.J.
(3)
+
-
Bonenkamp, J.J.
(3)
+
-
Borgers, J.S.W.
(3)
+
-
Dekkers, O.M.
(3)
+
-
Fehrmann, R.S.N.
(3)
+
-
Grijpink-Ongering, L.G.
(3)
+
-
Houdt, W.J. van
(3)
+
-
Jochems, A.
(3)
+
-
Long, G.V.
(3)
+
-
May, A.M.
(3)
+
-
Menzies, A.M.
(3)
+
-
Oosting, S.F.
(3)
+
-
Stevense-den Boer, M.
(3)
+
-
Thienen, J.V. van
(3)
+
-
Verhoef, C.
(3)
+
-
Versluis, J.M.
(3)
+
-
Baarle, D. van
(2)
+
-
Beerepoot, L.V.
(2)
+
-
Bhattacharya, A.
(2)
+
-
Bierman, C.
(2)
+
-
Bloem, M.
(2)
+
-
Bloemendal, H.J.
(2)
+
-
Boekhout, A.H.
(2)
+
-
Boer, M.A.M.S.D.
(2)
+
-
Boer, M.S.D.
(2)
+
-
Ch'ng, S.
(2)
+
-
Colebatch, A.J.
(2)
+
-
DOCC Investigators
(2)
+
-
Diest, P.J. van
(2)
+
-
Duin, I.A.J. van
(2)
+
-
Eechoute, K.
(2)
+
-
Eertwegh, A.J. van den
(2)
+
-
Elias, S.G.
(2)
+
-
Ellebaek, E.
(2)
+
-
Els, C.A.C.M. van
(2)
+
-
Gelderblom, H.
(2)
+
-
Gonzalez, M.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hage, J.A. van der
(2)
+
-
Hamberg, P.
(2)
+
-
Heuvel, N.M.J. van den
(2)
+
-
Hiltermann, T.J.N.
(2)
+
-
Jozwiak, K.
(2)
+
-
Kamphuis, A.M.
(2)
+
-
Klop, W.M.C.
(2)
+
-
Kvistborg, P.
(2)
+
-
Leeneman, B.
(2)
+
-
Leiner, T.
(2)
+
-
Lijnsvelt, J.M.
(2)
+
-
Mathijssen, R.H.J.
(2)
+
-
Mulder, E.E.A.P.
(2)
+
-
Oomen-de Hoop, E.
(2)
+
-
Pasmooij, A.M.G.
(2)
+
-
Pennington, T.E.
(2)
+
-
Poll-franse, L.V. van de
(2)
+
-
Rawson, R.V.
(2)
+
-
Reijers, I.L.M.
(2)
+
-
Rimmelzwaan, G.F.
(2)
+
-
Rots, N.Y.
(2)
+
-
Rozeman, E.A.
(2)
+
-
Rutkowski, P.
(2)
+
-
Saw, R.P.M.
(2)
+
-
Scolyer, R.A.
(2)
+
-
Shannon, K.F.
(2)
+
-
Sikorska, K.
(2)
+
-
Smit, E.F.
(2)
+
-
Spillane, A.J.
(2)
+
-
Stevense-den Boer, M.A.
(2)
+
-
Tinteren, H. van
(2)
+
-
Uyl-de Groot, C.A.
(2)
+
-
Verhoeff, J.J.C.
(2)
+
-
Verver, D.
(2)
+
-
Wessels, J.A.M.
(2)
+
-
Wiel, B.A. van de
(2)
+
-
Show more
Language
en
(57)
+
-
Search results
(1 - 24 of 57)
Pages
1
2
3
›
››
show grid
show list
save search
The predictive value of FDG PET/CT for determining progression-free survival in advanced stage III-IV BRAF-mutated melanoma patients treated with targeted therapy
A prediction model for response to immune checkpoint inhibition in advanced melanoma
BRAF/MEK inhibitor rechallenge in advanced melanoma patients
Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy
Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohort
The PRO-RCC study
Real-world outcomes of ipilimumab plus nivolumab combination therapy in a nationwide cohort of advanced melanoma patients in the Netherlands
A survival tree of advanced melanoma patients with brain metastases treated with immune checkpoint inhibitors
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
Adjuvant treatment of in-transit melanoma
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma
Population mortality in advanced melanoma patients with and without response and progression
Adjuvant BRAF-MEK inhibitors versus Anti PD-1 Therapy in stage III melanoma
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
ASO visual abstract
Association of immune-related adverse event management with survival in patients with advanced melanoma
Is a history of optimal staging by sentinel lymph node biopsy in the era prior to adjuvant therapy associated with improved outcome once melanoma Patients have progressed to advanced disease?
End-of-life use of systemic therapy in patients with advanced melanoma
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma
BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma
Response to immune checkpoint inhibitors in acral melanoma
Pages
1
2
3
›
››